Skip to main content
Download PDF

Retraction Note: PIWIL2 restrains the progression of thyroid cancer via interaction with miR-146a-3p

BMC Endocrine Disorders volume 25, Article number: 127 (2025) Cite this article

The Original Article was published on 29 August 2023

Retraction Note: BMC Endocrine Disorders (2023) 23:184

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12902-023-01416-0

The Editor has retracted this article because the authors were not able to provide appropriate documentation of approval from the relevant ethics committees.

Authors disagree with the retraction of the paper.

Author information

Author notes

  1. Xiaoxiao Lu, Qingyun Zhu and Hong Du contributed equally to this work.

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Punan Hospital, Pudong New Area, Shanghai, 200125, China

    Xiaoxiao Lu

  2. Department of Intervention, Gongli Hospital, Naval Medical University, Shanghai, 200135, China

    Qingyun Zhu

  3. Department of General Practice, Hudong Community Health Service Centre, Pudong New Area, Shanghai, 200129, China

    Hong Du

  4. Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai, 200135, China

    Mingjun Gu & Xiangqi Li

Authors
  1. Xiaoxiao Lu
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Qingyun Zhu
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Hong Du
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Mingjun Gu
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Xiangqi Li
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence to Mingjun Gu or Xiangqi Li.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, X., Zhu, Q., Du, H. et al. Retraction Note: PIWIL2 restrains the progression of thyroid cancer via interaction with miR-146a-3p. BMC Endocr Disord 25, 127 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12902-025-01950-z

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12902-025-01950-z

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us